Tinea capitis is the most common pediatric dermatophyte infection. Optimal treatment regimen differs according to the type of the dermatophyte involved.The aim of this work was to study the trichoscopic …
Dermatologic manifestations of COVID-19: a comprehensive systematic review.
Recent reports have suggested that there may be dermatologic manifestations of COVID-19. We searched 12 databases for peer-reviewed or pre-print published studies until July 15, 2020, for this PRISMA-compliant review …
Chilblains-like lesions and SARS-CoV-2 in children: an overview in therapeutic approach.
SARS-CoV-2 (Severe Acute Respiratory Syndrome, Coronavirus, type 2) is the virus responsible for the global pandemic of Coronavirus disease 2019 (COVID-19) that began in China in December 2019. The variability …
Chilblain-like lesions with prominent bullae in a patient with COVID-19.
A 27-year-old patient presented with acral chilblain-like lesions atypical of dermatological presentations appearing in current reports of COVID-19. Prominent bullae had formed on the dorsa of her toes and became …
ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility.
Angiotensin-converting enzyme-2 ( ACE2 ) receptor has been identified as the key adhesion molecule for the transmission of the SARS-CoV-2. However, there is no evidence that human genetic variation in …
Dermatological education for the 21st century: prioritizing diversity.
All education, including medical education, reflects society’s trends and needs. Skin and skin pigmentation have both personal and societal effects on an individual. During the protests following the killing of …
Measurement properties of the Patient-Reported Outcomes Information System (PROMIS® ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.
Itch is the most common and burdensome symptom of atopic dermatitis (AD, also simply known as eczema). However, there is limited data to support the validity of different approaches to …
Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients.
Most data on cutaneous manifestations of COVID-19 rely on the evaluation of hospitalized patients. Conversely as COVID-19 requires social isolation many low-symptomatic individuals develop dermatologic manifestations which prevalence is underestimated. …
5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia.
We have previously reported that men with androgenetic alopecia (AGA) are more likely to present with severe COVID-19 symptoms, potentially implicating androgen sensitivity as a risk factor for COVID-19.1-3 As …
Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey.
COVID-19 pandemic has a significant impact on public health, whether directly or indirectly. The first case was seen in Turkey on March 11, and the World Health Organization (WHO) declared …